The processes that trigger the severe muscle atrophy and loss of myosin in critical illness myopathy (CIM) are poorly understood. It has been reported that muscle disuse alters Ca 2+ handling by the sarcoplasmic reticulum. Since inactivity is an important contributor to CIM, this finding raises the possibility that elevated levels of the proteins involved in Ca 2+ handling might contribute to development of CIM. CIM was induced in 3-5 month-old rats by sciatic nerve lesion and infusion of dexamethasone for 1 week. Western blots revealed increased levels of ryanodine receptor (RYR) isoforms 1 and 2 as well as the dihydropyridine receptor (DHPR/Ca V 1.1). Immunostaining revealed a subset of fibers with elevation of RYR1 and Ca V 1.1 that had severe atrophy and disorganization of sarcomeres. These findings suggest increased Ca 2+ release from the sarcoplasmic reticulum may be an important contributor to development of CIM. To assess the endogenous functional effects of increased intracellular Ca 2+ in CIM, proteolysis of α-fodrin, a well-known target substrate of Ca 2+ -activated proteases, was measured and found to be 50% greater in CIM. There was also selective degradation of myosin heavy chain relative to actin in CIM muscle. Taken together, our findings suggest that increased Ca 2+ release from the sarcoplasmic reticulum may contribute to pathology in CIM.
INTRODUCTION
Critical illness myopathy (CIM) is the most common cause of weakness in patients in the intensive care unit (25, 29) . Patients often require prolonged ventilator support secondary to pulmonary muscle weakness, and do not regain full strength for many months after their acute illness (11, 20) . It is now appreciated that weakness following critical illness is the leading cause of disability in patients who survive acute respiratory distress syndrome (20, 22) .
Most animal studies of CIM have been carried out in rat a model that involves pairing muscle inactivity, induced by denervation, with systemic administration of corticosteroids (50) .
The model was established to mimic the clinical situation in patients who develop CIM following infusion of neuromuscular blocking agents and corticosteroids (10, 36) . A central issue is whether denervation of muscle mimics the effects of unloading muscle caused by neuromuscular blocking agents in patients. A recent study compared muscle treated with denervation alone to muscle treated with the combination of neuromuscular blockade and corticosteroids and found differences (42) . We have previously found that the addition of corticosteroids to denervation has profound effects on muscle (47, 48) , which suggests the differences were likely due to treatment with corticosteroids rather than difference between denervation and neuromuscular block. There is evidence suggesting that denervation has little effect other than loss of electrical activity on some muscle properties (34, 35, 62) . Muscle mass is similarly reduced by denervation and disuse (67)(for review see (14) ). Denervation and neuromuscular blockade have been directly compared and found to have nearly identical effects on skeletal muscle electrical properties (6) .
There are a number of abnormalities that contribute to weakness in CIM. These include selective loss of myosin (10, 30, 31, 40, 43, 44, 53) , disorganization of sarcomeres (10, 53) , dramatic muscle atrophy (28) , and electrical inexcitability of muscle (46, 49) . All of these Upregulation of Ca V 1.1 and ryanodine receptor in CIM 4 features occur in the steroid denervation rat model of the disease (38, 40, 48, 50) . It thus appears that the steroid-denervation rat model of CIM recreates all of the contributors to weakness found in patients.
Despite a great deal of research, the inciting events that trigger the various contributors to weakness in CIM remain poorly understood. There are hints from different lines of work that suggest dysregulation of Ca 2+ handling may be an early event in CIM. It has been found that muscle disuse (a contributor to development of CIM) alters Ca 2+ handling by the sarcoplasmic reticulum (21) . Ca 2+ is elevated by dexamethasone treatment of skeletal muscle in vitro (23) .
Given these studies it appears highly likely that Ca 2+ handling is abnormal in denervated muscle treated with corticosteroids.
There are multiple pathways that contribute to regulation of intracellular Ca in skeletal muscle, including Ca 2+ entry through voltage gated L-type Ca 2+ channels on the muscle surface (mediated by the Ca V 1.2 isoform), Ca 2+ release from the sarcoplasmic reticulum (mediated by the coordinated action of the Ca V 1.1 Ca 2+ channel and the RYR1), and Ca 2+ entry via store operated Ca 2+ channels (mediated by ORAI 1) (12, 23, 24) . We measured levels of Ca 2+ handling proteins in these three pathways to determine whether increases in levels of proteins in any of these pathways might contribute to Ca 2+ dysregulation in CIM. Our data suggest increased levels of proteins involved in Ca 2+ release from the sarcoplasmic reticulum may contribute to development of severe atrophy in a subset of fibers in CIM.
Upregulation of Ca V 1.1 and ryanodine receptor in CIM 5
MATERIALS AND METHODS
Animal protocols were approved by the Institutional Animal Care and Use Committee at Wright State University.
Induction of CIM. Rat muscle was denervated by removing a 10-mm segment of the left sciatic nerve in isoflurane anesthetized adult female Wistar rats (250-350 g body weight).
Buprenorphine was given subcutaneously for postoperative analgesia. Dexamethasone (4 mg/kg/day) was infused via an Alzet osmotic pump placed subcutaneously in the back (Model 2 ml1, Durect, Cupertino, CA) on the day of denervation. Control rats were treated with placement of osmotic pumps containing vehicle alone (50% DMSO, 15% ETOH and 35% water). Steroid treatment induced severe weight loss that may be due, in part, to reduced food intake (51) . Rats were given daily intraperitoneal injections of antibiotics (0.2 mls of 2.27% Baytril, Bayer, Shawnee Mission, KS). The injection of antibiotics substantially improved survival of steroid-treated rats. Seven days after surgery rats were sacrificed by carbon dioxide inhalation, and the tibialis anterior, soleus and gastrocnemius muscles removed.
Preparation of Muscle Membranes. Membranes were prepared from gastrocnemius muscles of control or CIM rats as reported previously (24) . Muscles were harvested, weighed, frozen in liquid nitrogen, and stored at -70 until use. Muscles were thawed on ice for approximately 10 minutes, minced finely on a glass plate on ice prior to incubating in sucrose buffer with protease and phosphatase inhibitors for 15-30 minutes to allow the inhibitors to penetrate the muscle. Between 5 and 10 mls of buffer was used per gram of tissue. The remaining sample centrifuged in a SM24 rotor at 4500 x g for 15 minutes. The supernatants were removed, centrifuged again, and the final supernatant centrifuged in a SW55 rotor at 138,000 x g for 1 hr. The pellets from this last step were resuspended in fresh sucrose buffer with inhibitors and used as the membrane fraction.
For purification of sodium channels, membranes were solubilized using NP40 and the sodium channel fraction sequentially purified on DEAE-Sepharose and wheat germ agglutinin columns as described in (26) . For all membrane preparation and channel purification procedures, all samples, equipment, and buffers were kept at 0-4 o C.
Preparation of Whole Muscle
Homogenates. Whole muscle homogenates were prepared from soleus, gastrocnemius and tibialis anterior muscles. Aliquots taken for whole muscle homogenates were combined with 0.5 ml of 20% SDS, 100 mM Tris, pH 8.0 and incubated at 65 o C for 20 minutes, vortexing vigorously at the beginning, halfway point, and end of the incubation. The homogenates were centrifuged at 13,700 x g in a microfuge for 30 minutes and the supernatants taken as the whole muscle homogenate.
SDS-PAGE and Western Blots. Membrane fractions and whole muscle homogenates
were assayed for protein content using the Lowry protein assay, and equal amounts of protein were loaded for control and CIM samples for each protein assessed (40-100 µg per lane). SDS-PAGE was performed on Criterion 4-20% acrylamide gels (BioRad), and Western transfers were carried out in a Criterion transfer apparatus using nitrocellulose as the blotting medium.
Following transfer, the blots were washed with phosphate-buffered saline/0.1 % Tween (PBS/Tween) and the transfer efficiency assessed by staining with Ponceau S Red. After removing this stain by washing with PBS/Tween, the blots were block in 1% I-Block (Tropix) for 1 hour to overnight, incubated with 1 st antibody for 2 hrs, washed, incubated with mouse or rabbit secondary antibody conjugated to alkaline phosphatase (Tropix) and visualized using CDP-Star (Tropix) and a Fujifilm LAS-3000 CCD camera.
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For myosin/ α-actin blots, the myosin signal in each lane was normalized to the α-actin in that lane since previous work has shown selective loss of myosin relative to α-actin in CIM (43) .
For all blots, the average of the signal in the control muscle was set at 100% and individual control and CIM samples were calculated as a percentage of that. For membrane proteins, the signal for individual proteins was normalized to total membrane protein rather than a particular loading control. This approach was chosen as it appeared that expression of many proteins are changed by the treatments used and total protein seemed a less biased normalization tool rather than relying on any one protein. Ponceau S Red staining indicated that the overall protein in the samples was similar (data not shown). Our approach to normalization appeared validated by the finding that some proteins went up (RYR1, RYR2, and Ca V 1.1) while other proteins went down (Ca V 1.2 and ORAI type 1) and levels of yet other proteins were not statistically changed (Na v 1.4 and β-tubulin).
The primary antibodies used in this study were obtained from the following sources: Identification of fibers in which RYR1 levels were elevated was done qualitatively and then confirmed quantitatively. First, two independent reviewers examined muscle sections and were able to reproducibly identify the same fibers. To confirm qualitative impressions, fibers were imaged as described above and intensity was analyzed using Image Pro software. Image stacks were flattened using the flat-plane in focus projections and the mean pixel intensity of each fiber was measured. For quantification of the number of fibers with elevated RYR1 all fibers in a single cross section of the entire tibialis anterior were counted.
Statistical Analysis. All Western blot and muscle weights were compared using the Student's t test to determine statistical significance. All means are given ± the SEM. For analysis of rat to rat differences in the percent of fibers with elevated levels of RYR, Fisher's Exact test was used.
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RESULTS

RYR protein is present at higher levels in CIM muscle
Membranes prepared from muscles of individual animals were screened in Western blots with a monoclonal antibody which recognizes both RYR1 and RYR2 ( Fig. 1 A) . There was an approximately 40% increase in RYR expression in CIM (Fig. 1B) . Using sub-type specific antibodies to further analyze which RYR isoform was contributing the most to this increase indicated that the majority of the increase was due to increased expression of the skeletal muscle-specific RYR1 isoform, which was the most predominant RYR expressed in both control and CIM skeletal muscle, although there was increased expression of both RYR1 and RYR2 in CIM ( Table 1) . Given the close interaction between RYR and voltage-gated Ca 2+ channels (12), the expression of Ca 2+ channels was also determined in control and CIM muscle ( Fig. 1C and Table 1 ). There was a concomitant increase of Ca V 1.1 with RYR1, while expression of the Ca V 1.2 decreased in CIM. Expression of calcium release activated channels (ORAI, Type 1) also decreased in CIM (Table 1) . Taken together, these data suggest that there is a parallel increase in Ca V 1.1 and RYR1 that could lead to increased Ca 2+ release from the sarcoplasmic reticulum.
The elevation of RYR1 by Western blot could be due to either uniform elevation of RYR in all muscle fibers or elevation in a subset of fibers. In control muscle RYR1 staining was similar in intensity in all fibers and sarcoplasmic reticulum was organized into a series of parallel lines running perpendicular to the length of the fiber (Fig 2A) . In most CIM muscles (5/7) the increase in RYR1 staining was uniform such that no differences could be noted between fibers.
However, in 2/7 CIM muscles, there was striking elevation of RYR1 in a subset (28/309) of fibers ( Fig 2B-E, Table 2 ). On average fibers with elevated intensity of RYR staining had an increase in pixel intensity of 228% ± 53% relative to other fibers in the same field. In the other 5 muscles only 4/777 fibers exhibited marked elevation in RYR1 staining. Fibers in which RYR1 Upregulation of Ca V 1.1 and ryanodine receptor in CIM 10 was elevated were all abnormal in appearance. In some fibers with increased RYR1 there was severe disorganization of the sarcoplasmic reticulum such that no organization of RYR1 staining could be discerned (Fig 2B, E) . In other fibers with elevated RYR1 there was severe atrophy (Fig. 2C ). We found that the Ca V 1.1 calcium channel was also increased in the subset of fibers with high levels of RYR1 (Fig 3) . Elevation of Ca 2+ can trigger numerous pathologic processes and it has been suggested that calpains and caspases, potent Ca 2+ -activated proteases, are activated in CIM (13, 52, 57, 58) . We performed immunostaining and found that calpain II was elevated in muscle fibers with elevated RYR1 (Fig. 4) .
Endogenous proteolysis is enhanced in CIM
To determine if endogenous calpain activity was elevated in CIM muscles in a functional test, proteolysis of the cytoskeletal protein α-fodrin, a well-known target of calpain (61), was analyzed by Western blot (Fig. 5 ). There was a 50% increase in the calpain-cleaved form of αfodrin in CIM tissue, production of an approximately 150 kDa fragment, consistent with increased calpain activity. Since cleavage of α-fodrin by caspases results in a cleavage product that runs at approximately 120 kDa (61), these data implicate calpains not caspases in endogenous proteolysis of α-fodrin under these conditions. Calpains are also thought to initiate breakdown of myofibrillar proteins (9) . One of the hallmarks of CIM is a selective degradation of myosin that results in a reduced myosin/actin ratio (10, 31, 53) . We measured the myosin/actin ratio by Western blot in control muscle and CIM muscles (Fig. 6) . Consistent with reports from other laboratories, there was considerable reduction in the myosin/actin ratio for both fast myosin II and slow myosin I in both the gastrocnemius and soleus CIM muscles. However, in the tibialis anterior there was little reduction in the myosin/actin ratio for either myosin isoform (Fig. 6 ). Analysis of myosin expression in the gastrocnemius by immunohistochemistry indicated that the subset of Upregulation of Ca V 1.1 and ryanodine receptor in CIM 11 extremely atrophied fibers with high levels of RYR1 expressed fast myosin II (Fig. 7) . Staining with slow myosin labeled only a small percentage of fibers and did not label any of the fibers with high levels of RYR1 (data not shown).
Consistent with the observed enhanced catabolic processes observed in CIM muscle, all muscles examined; gastrocnemius, soleus, and tibialias anterior, exhibited significant atrophy (50% by set weight, Table 3 ). Previous work indicated that fiber cross-sectional area decreased by a much greater degree in CIM muscle compared to control, denervation alone or steroid treatment alone, indicating that the combination of corticosteroid treatment and denervation is necessary to induce this severe atrophy (48).
RYR1 is modified in CIM
In addition to the changes in levels, we found evidence that RYR1 is sometimes modified in CIM. While purifying sodium channels from CIM muscle membranes, the RYR1 sometimes co-purified in the sodium channel fraction (Fig. 8) . That RYR1 was present in CIM but not control purifications suggests that some type of modification and/or protein association is different in CIM. We observed this striking co-purification in 2/5 purifications, similar to the occurrence of a subset of fibers with very high RYR levels in 2/7 muscles.
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DISCUSSION
This study addresses both global and fiber-specific changes in patterns of expression of a subset of Ca 2+ signaling proteins in CIM. In all muscles examined, there was an elevation in ryanodine receptor type I (RYR1) channels in the muscle membrane fraction that was accompanied by a parallel increase in Ca V 1.1. Additionally, there was a global increase in calpain-mediated cleavage of α-fodrin. On a more restricted level in terms of number of affected rats (2/7 CIM rats) and numbers of fibers (10% of fibers in affects rats), immunostaining demonstrated that fibers with the greatest elevation in Ca V 1.1 and RYR1 had the greatest atrophy and disorganization of sarcomeres, raising the possibility that elevation of the levels of Ca handling proteins induced toxicity. Our findings suggest that increased Ca 2+ release from the sarcoplasmic reticulum may play a role in triggering muscle pathology in CIM.
Our data demonstrate that proteins associated with Ca 2+ release from the sarcoplasmic reticulum are elevated in CIM while levels of Ca 2+ handling proteins involved in entry of Ca 2+ during muscle action potentials (Ca v 1.2) and Ca 2+ entry via store-operated channels (ORAI 1) were reduced. These data suggest that regulation of intracellular Ca 2+ in CIM is highly likely to be altered. The upregulation of Ca v 1.1 and RYR1 appeared to be due to coordinated regulation, since both proteins were co-regulated at a global level, as demonstrated by increased expression in Western analysis, and on a fiber by fiber basis, as demonstrated by immunostaining. As it is well-known that RYR1 and Ca V 1.1 have a strong association in skeletal muscle (4, 12, 41, 54) it is not surprising that levels were co-regulated, however, our study does not demonstrate a causal link.
There was also greater functional activity of calpain, as indicated by increased appearance of a calpain-specific α-fodrin cleavage product in CIM muscle. The increased calpain activity likely initiates degradation of myosin heavy chain (17) , although this degradation is likely completed by the ubiquitin-proteosome pathway, as it is the common pathway in all Upregulation of Ca V 1.1 and ryanodine receptor in CIM 13 known triggers of muscle atrophy, including glucocorticoid treatment and denervation (7, 9, 17) .
The muscle atrophy in CIM, which is found uniformly in all muscles from all animals, is likely due in part to this increased muscle proteolysis. Taken together, our observations are consistent with a causal link between elevation of the Ca v 1.1-RYR1 complex and myosin proteolysis and muscle atrophy.
In 2/7 of rats there was a subset of severely atrophied fibers that had very high levels of calpain, a finding that raises the possibility of future death of the fibers (55) . In CIM there is a subset of patients who have modest elevations in serum levels of the muscle enzyme creatine kinase due to death of muscle fibers (8, 18, 46) . The etiology of the death of muscle fibers in CIM has never been determined. Our data in rats suggest that a potential triggering mechanism is dramatic up-regulation of Ca handling proteins in a subset of fibers. Future studies measuring Ca 2+ handling proteins on a fiber by fiber basis in patient biopsies will determine if this is the case.
In the rat model of CIM, muscle fibers are not electrically active as they are denervated and most of the fibers are electrically inexcitable so there is little of the spontaneous activity that normally occurs following denervation (48). Normally there is no Ca 2+ release from the SR in the absence of electrical activity (12) . This raises the question of why fibers with elevated levels of Ca v 1.1 and RYR1 had the greatest atrophy and disruption of sarcomere organization. One possibility is that there is leak of Ca 2+ from the SR in the absence of electrical activity in these fibers due to modification of the RYR1 protein or its protein association partners in CIM.
We found evidence that in addition to the increase in levels of RYR1, in a subset of muscles, there appeared to be modification of the channel that affected its binding to resins used for purification of sodium channels. The ryanodine receptor is regulated at many levels such that a number of alterations might contribute to increased Ca 2+ release from the sarcoplasmic reticulum. Ryanodine receptors are associated with FKBP12 and FKBP12.6, also Upregulation of Ca V 1.1 and ryanodine receptor in CIM 14 known as calstabin 1 and 2, which bind the RYR1 and RYR2, respectively, in a 1:1 stoichiometry (32, 37) . The binding of the calstabins to the RYRs is regulated through a PKAmodified serine on the RyR receptor, Ser 2844 for RYR1 and Ser 2809 for RYR2, with hyperphosphorylation at these sites causing loss of calstabin binding and resulting in Ca 2+ leak under resting conditions (32, 63) . In addition to the PKA-modification of the ryanodine receptors, they are also covalently modified by S-nitrosylation, S-glutathionylation, and oxidation at several cysteines (1) . Modification of the RYR1 at specific cysteines alters probability of channel opening and association with other proteins, including calstabins and calmodulin (1, 5, 56) .
Collectively, these post-translational modifications of RyRs could contribute to altered function of RYRs in CIM that results in Ca 2+ leak in the absence of electrical activity.
As Ca 2+ leak from the SR may contribute to development of CIM we tested whether a drug that lessens sarcoplasmic reticulum Ca 2+ release through RYRs might reduce CIM muscle pathology. We used azumolene, a more-water soluble analog of dantrolene, since it combined ease of use and efficacy (27, 68) . Dantrolene has been shown to reduce muscle protein degradation early in the course of sepsis in rats in vivo (64, 66) . Unfortunately at high doses azumolene appears to increase mortality and at lower doses it did not significantly reduce either atrophy or loss of myosin (data not shown). Thus, preliminary efforts at treating CIM through reduction of Ca release from the SR were not encouraging.
The rat model of CIM
Comparison of data from the tibialis anterior, gastrocnemius and soleus muscles addresses specific concerns about the rat steroid-denervation model of CIM employed in this study. Rats with lesions of the sciatic nerve still walk despite denervation of muscles below the knee. Lower leg muscles in rats with sciatic nerve lesions thus experience passive loading and unloading despite being denervated and thus do not mimic the situation in critically ill patients where muscles are continuously unloaded. However, this is not true for all muscles in the leg.
While the gastrocnemius and soleus are weight bearing muscles that experience load/stretch when the foot of a denervated rat leg is placed on the ground, the tibialis anterior is not a load bearing muscle and thus never experiences loading/stretch after a sciatic nerve lesion (65) .
The only time the tibialis anterior experiences passive stretch is when the gastrocnemius and soleus contract and this does not happen in a leg where the sciatic nerve has been lesioned.
Thus the tibialis anterior in our rat model shares both loss of activity as well as unloading with critically ill patients. For all three muscles, there was a similar degree of atrophy, as indicated by the loss of wet weight (Table 3 ). Relative loss of myosin was least severe in the unloaded tibialis anterior muscle while the gastrocnemius muscle and soleus muscle lost similar amounts of myosin. As the loaded gastrocnemius and soleus muscles were at least as severely affected as the unloaded tibialis anterior, our data are most consistent with the possibility that loss of muscle activity rather than unloading is the key risk factor for development of CIM in rat.
In the rat model we use, there are two contributing risk factors to CIM, steroid treatment and denervation. Previous work has shown that each of these treatments individually has profound effects on muscle. Steroid treatment induces severe muscle weight loss, reduces the cross-sectional area of type IIB and IIX myofibers, reduces expression of myosin IIx and IIB myosin, and reduces force produced by the myofibers (33, 39, 45, 59, 60) . Denervation reduces expression of myosin IIx and IIB, increases net protein degradation via the ubiquitinproteosome pathway, and increases and activates a subset of cell signaling factors involved in atrophy (2, 3, 15, 16) . Previous work from our laboratory indicates that these two risk factors have a powerful synergistic effect (47, 48). One feature of the animal model we use that would be potentially more severe than in patients is the loss of trophic factors from nerve (19) . It is our view that CIM is a common endpoint that can be induced by a number of "triggers" or risk factors in any given patient.
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Perspectives and Significance
In this study we demonstrate that levels of proteins involved in Ca 2+ release from the sarcoplasmic reticulum are elevated in CIM. These findings suggest increased Ca 2+ release from the sarcoplasmic reticulum may be an important contributor to development of CIM. Count of fibers with elevated levels of RYR on immunostained longitudinal sections of tibialis anterior muscle. Fisher's Exact test revealed that there was a statistically significant difference in the percentage of abnormal fibers between rats (p < .0001).
GRANTS:
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